Guest speaker Dr Steven Suchting, Investment Director, Life Science, IP Group (international venture capital firm) will be presenting on How investors approach therapeutic opportunities. 

Register by 15 March to rsvp@uniquest.com.au.

Venture investors IP Group have entered into a unique partnership with the University of Queensland to help researchers to turn exceptional ideas into world-changing businesses. Dr Steven Suchting for the IP Group Life Science team will discuss the specific challenges with therapeutic opportunities and how they assess new technologies and make investment decisions.  He will share recent case-studies from their Australian portfolio to illustrate what made these opportunities investible.  

Venue

Translational Research Institute
Room: 
2003